Compare SLF & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SLF | KVUE |
|---|---|---|
| Founded | 1871 | 2022 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Advertising | Specialty Chemicals |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.7B | 34.2B |
| IPO Year | 2000 | 2023 |
| Metric | SLF | KVUE |
|---|---|---|
| Price | $77.63 | $17.26 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 14 |
| Target Price | N/A | ★ $19.50 |
| AVG Volume (30 Days) | 315.9K | ★ 22.6M |
| Earning Date | 11-04-2026 | 11-02-2026 |
| Dividend Yield | 3.48% | ★ 4.76% |
| EPS Growth | N/A | ★ 40.74 |
| EPS | N/A | ★ 0.48 |
| Revenue | N/A | ★ $15,124,000,000.00 |
| Revenue This Year | $23.64 | $3.12 |
| Revenue Next Year | $3.01 | $2.38 |
| P/E Ratio | ★ $14.79 | $37.53 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $57.22 | $14.02 |
| 52 Week High | $84.38 | $20.13 |
| Indicator | SLF | KVUE |
|---|---|---|
| Relative Strength Index (RSI) | 34.98 | 34.40 |
| Support Level | $76.95 | $17.01 |
| Resistance Level | $78.98 | $17.88 |
| Average True Range (ATR) | 1.03 | 0.26 |
| MACD | -0.30 | 0.00 |
| Stochastic Oscillator | 0.23 | 1.92 |
Sun Life Financial is one of the Big Three Canadian life insurers. The Canadian business contributed around 35% of its 2025 adjusted earnings. In that segment, the firm provides health, life insurance, and annuity products to individual and group customers. Its US business is mostly group health and contributed about 17% of the firm's adjusted earnings in 2025. Sun Life also offers life insurance and wealth products in several Asian markets with a strong presence in Hong Kong and the Philippines. The Asia segment contributed around 18% of adjusted 2024 earnings. Its asset management business had around CAD 1.2 trillion total assets under management or administration at the end of 2025 and represents around 30% of the firm's earnings.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.